熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
熱門詞： 進(jìn)口電動(dòng)溫度調(diào)節(jié)閥結(jié)構(gòu)圖|進(jìn)口電動(dòng)溫度調(diào)節(jié)閥數(shù)據(jù)表進(jìn)口電動(dòng)高溫調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)高溫法蘭調(diào)節(jié)閥進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥-德國(guó)進(jìn)口電動(dòng)蒸汽調(diào)節(jié)閥
BioAlliance 法國(guó)BioAlliance Pharma
成立于1997 年。 主要發(fā)展治療癌癥、病毒性疾病 ( 如 HIV) 以及伺機(jī)性感染等醫(yī)藥市場(chǎng)
Created in 1997, BioAlliance Pharma develops its activities and focuses them on rapidly evolving therapeutic markets -cancer, serious viral diseases (such as HIV) and opportunistic infections – to respond to the needs of specialist physicians, particularly in the hospital setting.
The Company designs and manufactures innovative products, based on active pharmaceutical ingredients already recognized on the market with a proven efficacy and tolerance profile, as well as developing new entities. It more specifically targets diseases for which the medical needs are insufficiently met and where the phenomenon of drug resistance leads to particularly serious consequences.
Our teams have the key competencies required to identify, design, develop and register drugs in Europe and the USA. Our development choices enable us to balance the risks in our product portfolio and to accelerate market launch of our products.
Positioning ourselves on our targeted markets, we have a European sales force and pursue an active license policy with industrial partners, particularly in the United States and Asia. This strategy allows us to diversify our direct and indirect revenues, while capitalizing on our structures and promoting synergies.
知識(shí)產(chǎn)權(quán)侵權(quán)投訴：不生產(chǎn)任何產(chǎn)品所有產(chǎn)品均來(lái)自產(chǎn)品的生產(chǎn)廠商、代理商、經(jīng)銷商，如有侵權(quán)請(qǐng)聯(lián)系：400-006-7520 ，我們會(huì)在第一時(shí)間處理
本網(wǎng)站所有產(chǎn)品與藥品無(wú)關(guān)
滬公網(wǎng)安備31011502016460號(hào)
